Igen Will Boost Bio-Defense Product Line With Salmonella, E. Coli POC Tests
This article was originally published in The Gray Sheet
Executive Summary
Igen will seek FDA 510(k) clearance for an expanded infectious disease test menu following the introduction of a new point-of-care instrument
You may also be interested in...
Roche To Appeal $505 Mil. Jury Decision Granting Igen Elecsys Rights
Igen International will gain the rights to Roche Diagnostic's Elecsys diagnostic product line under a $505 mil. verdict reached Jan. 10 in Maryland federal court
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.